[Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer].
Teramoto
S
S
Kita
E
E
Mikasa
K
K
Hamada
K
K
Konishi
M
M
Maeda
K
K
Sakamoto
M
M
Tsujimoto
M
M
Mori
K
K
Sawaki
M
M
Narita
N
N
D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000737:chemistry* / Q000628:therapy; D017291:Clarithromycin / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology* / Q000627:therapeutic use; D007371:Interferon-gamma / Q000235:genetics*; D018664:Interleukin-12 / Q000235:genetics*; D008175:Lung Neoplasms / Q000737:chemistry* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000032:analysis*
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D012333:RNA, Messenger; D018664:Interleukin-12; D007371:Interferon-gamma; D017291:Clarithromycin